###begin article-title 0
Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC
###end article-title 0
###begin p 1
###xml 39 57 39 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">makriga@ircm.qc.ca</email>
CORRESPONDENCE Andrew P. Makrigiannis: makriga@ircm.qc.ca
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 788 789 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 1034 1038 <span type="species:ncbi:10090">mice</span>
###xml 1053 1058 <span type="species:ncbi:10090">mouse</span>
Plasmacytoid dendritic cells (pDCs) are an important source of type I interferon (IFN) during initial immune responses to viral infections. In mice, pDCs are uniquely characterized by high-level expression of Ly49Q, a C-type lectin-like receptor specific for class I major histocompatibility complex (MHC) molecules. Despite having a cytoplasmic immunoreceptor tyrosine-based inhibitory motif, Ly49Q was found to enhance pDC function in vitro, as pDC cytokine production in response to the Toll-like receptor (TLR) 9 agonist CpG-oligonucleotide (ODN) could be blocked using soluble monoclonal antibody (mAb) to Ly49Q or H-2Kb. Conversely, CpG-ODN-dependent IFN-alpha production by pDCs was greatly augmented upon receptor cross-linking using immobilized anti-Ly49Q mAb or recombinant H-2Kb ligand. Accordingly, Ly49Q-deficient pDCs displayed a severely reduced capacity to produce cytokines in response to TLR7 and TLR9 stimulation both in vitro and in vivo. Finally, TLR9-dependent antiviral responses were compromised in Ly49Q-null mice infected with mouse cytomegalovirus. Thus, class I MHC recognition by Ly49Q on pDCs is necessary for optimal activation of innate immune responses in vivo.
###end p 3
###begin p 4
###xml 310 314 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
###xml 322 325 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 370 375 <span type="species:ncbi:10090">mouse</span>
Abbreviations used: B6, C57BL/6; BAC, bacterial artificial chromosome; BST2, bone marrow stromal cell antigen 2; DOTAP, 1,2-dioleoyloxy-3-trimethylammonium-propane; ES, embryonic stem; ITAM, immunoreceptor tyrosine-based activation motif; ITIM, immunoreceptor tyrosine-based inhibitory motif; mDC, myeloid DC; MCMV, mouse CMV; MFI, mean fluorescence intensity; mPDCA-1, mouse PDC antigen 1; ODN, oligonucleotide; pDC, plasmacytoid DC; SHP, Src homology phosphatase; TLR, Toll-like receptor.
###end p 4
###begin p 5
L.-H. Tai and M.-L. Goulet contributed equally to this paper.
###end p 5
###begin p 6
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
Plasmacytoid DCs (pDCs) are potent antiviral effector cells that were originally identified by their plasma cell-like morphology and localization within the T cell zone of lymphoid tissue (1). Also termed type I IFN-producing cells, pDCs secrete more type I IFN on a per-cell basis than any other cell type (2-4). pDCs are especially important in controlling viral infections, a property highlighted by their selective expression of Toll-like receptor (TLR) 7 and TLR9 (5), which recognize single-stranded RNA and double-stranded DNA, respectively. pDCs do not express TLR2, TLR3, TLR4, and TLR5, explaining why they do not respond to common bacterial products recognized by other APCs.
###end p 6
###begin p 7
###xml 304 305 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 387 388 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 390 391 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 567 568 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 572 573 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 577 578 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 590 591 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 657 658 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 979 980 967 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 998 999 986 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1152 1153 1140 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 1248 1249 1236 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1289 1290 1277 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1300 1302 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1314 1316 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1437 1439 1421 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1518 1520 1502 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 195 200 <span type="species:ncbi:10090">mouse</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 308 313 <span type="species:ncbi:10090">Mouse</span>
###xml 1229 1234 <span type="species:ncbi:10090">mouse</span>
###xml 1252 1257 <span type="species:ncbi:10090">mouse</span>
pDCs represent a rare cell type constituting approximately1% of bone marrow or splenic leukocytes and <0.5% of lymph node and peripheral blood leukocytes. However, their frequency varies between mouse strains with 129Sv mice possessing a significantly higher proportion of pDCs than other mouse strains (6). Mouse pDCs do not express the lineage markers CD19, CD3, DX5, CD14, or TER119 (7, 8). In addition to their selective pattern of TLR expression, pDCs and myeloid DCs (mDCs) are dissimilar in various other aspects. Unlike mDCs, pDCs are characterized by a CD11b-B220+Ly6C+ phenotype (7). Like mDCs, pDCs express CD11c but they do so at a lower level (8). Resting pDCs have been referred to as immature APCs because they express only low levels of CD86 and class II MHC, and they display little or no endocytic activity. However, upon TLR stimulation all three of these characteristics are up-regulated to allow pDCs to present antigenic peptides and optimally stimulate CD4+ T cell function (7). In addition, pDCs have been implicated in promoting mDC maturation and terminal B cell differentiation to functional antibody-producing plasma cells (1). Five different mAb reagents have been reported to specifically recognize mouse pDCs: 120G8 (6), mouse PDC antigen 1 (mPDCA-1), 440c (9), NS-34 (10), and 2E6 (11). The 440c mAb recognizes Siglec-H, a DAP12-coupled receptor that inhibits pDC function, including IFN-alpha secretion (12). 120G8 and mPDCA-1 both recognize bone marrow stromal cell antigen 2 (BST2) (13). NS-34 and 2E6 recognize Ly49Q, a member of the type II C-type lectin-like Ly49 family. Interestingly, most other Ly49 family members are exclusively expressed on NK, NKT, and T cell subsets, where they are known to regulate cytokine production and cell-mediated cytotoxicity via interactions with cognate class I MHC-related ligands on target cells.
###end p 7
###begin p 8
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q</italic>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49e</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 597 598 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 592 598 592 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 643 644 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 638 644 638 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>2</sub></italic>
###xml 654 655 654 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>3</sub></italic>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
###xml 228 233 <span type="species:ncbi:10090">mouse</span>
###xml 616 621 <span type="species:ncbi:10090">mouse</span>
Ly49Q is one of the more distantly related Ly49 family members, yet the receptor itself is highly conserved among three mouse haplotypes (C57BL/6 [B6], 129S6, and BALB/c) (14-16). To date, Ly49Q protein has been detected in all mouse strains tested (17), suggesting an important and conserved function for this receptor. The Ly49q gene defines the centromeric end of the B6, 129S6, and BALB/c Ly49 gene clusters. Interestingly, a homologous segment comprising Ly49q- and Ly49e-like genes is repeated three times in the 129S6 genome because of gene duplication (18). Therefore, in addition to Ly49q1, the 129-related mouse strains contain Ly49q2 and Ly49q3, but the latter two genes are considered pseudogenes because they lack exons 6 and 7, which encode the ligand-binding domain (18).
###end p 8
###begin p 9
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 203 205 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 714 716 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1009 1011 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
Ly49Q was first reported to be expressed at low levels on a proportion of Gr-1+ bone marrow myeloid precursor cells, on peripheral blood neutrophils (Gr1+CD11b+), and on IFN-gamma-activated macrophages (10). However, the function of the receptor on these cell types remains unknown. Ly49Q contains a cytoplasmic immunoreceptor tyrosine-based inhibition motif (ITIM), whereas it lacks a positively charged transmembrane residue, both of which are characteristics of inhibitory Ly49 receptors expressed by NK cells. Furthermore, similar to inhibitory Ly49 NK receptors, the Ly49Q ITIM has been reported to associate with the Src homology phosphatases (SHPs) 1/2 upon antibody-mediated cross-linking of the receptor (10). However, Ly49Q is not expressed by NK cells. Moreover, Ly49Q cross-linking on activated macrophages has been reported to induce cytoskeletal rearrangement leading to formation of polarized filopodia and lamellopodia; this suggests a role for Ly49Q in macrophage migration and phagocytosis (10).
###end p 9
###begin p 10
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 567 568 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 801 803 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 805 807 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 905 907 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 837 842 <span type="species:ncbi:10090">mouse</span>
In subsequent reports, a population of cells expressing significantly higher levels of Ly49Q than neutrophils and macrophages was identified (11, 17, 19). This cell population was originally defined as CD11c+B220+Gr1low and has been confirmed to represent pDCs (1, 20). Virtually all peripheral pDCs and the majority of bone marrow pDCs express Ly49Q. The subset of bone marrow pDCs lacking Ly49Q expression are thought to represent immature cells, such that acquisition of Ly49Q expression is linked to sequential development of functional pDCs (11, 19). These Ly49Q- pDCs do not respond to certain stimuli and are defective in the secretion of some cytokines. Ly49Q levels correlate well with pDC maturation, and receptor acquisition is further up-regulated by various stimuli, including IFN-alpha (17, 19). In some but not all inbred mouse strains, a subset of mDCs also expresses low levels of Ly49Q (17).
###end p 10
###begin p 11
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
We recently identified the classical class I MHC molecule, H-2Kb, as the cognate Ly49Q ligand (21). Using reporter cell analysis, a high-affinity ligand for Ly49Q was detected on tumor and normal ex vivo cells derived from H-2b haplotype mice (B6 and 129) but not on cells from the other mouse MHC haplotypes tested. Direct MHC surveillance by pDCs and the implications of this interaction for innate immunity remain to be investigated.
###end p 11
###begin p 12
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
The current study demonstrates a major role for Ly49Q-H-2Kb interactions in pDC production of IFN-alpha and, to a lesser extent, IL-12. Remarkably, the function of Ly49Q on pDCs appears to be stimulatory in nature, as revealed by cross-linking experiments despite the presence of a cytoplasmic ITIM. To confirm these in vitro findings and to ascertain the role of Ly49Q during immune responses, Ly49Q-null mice were generated and characterized. Ly49Q-null mice exhibit a severe defect in systemic IFN-alpha production after challenge with agonists and pathogens recognized by TLR7 and TLR9, which translates into weaker antiviral responses in vivo. We propose that Ly49Q recognition of self-MHC is necessary to regulate pDC cytokine responses to pathogens.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin title 14
Ly49Q interactions with class I MHC are necessary for IFN-alpha secretion by pDCs
###end title 14
###begin p 15
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 429 430 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 461 463 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 498 499 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 608 616 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 684 685 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 691 699 683 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 775 776 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
We have previously shown that H-2Kb is a ligand for Ly49Q (21), suggesting that pDC function may be regulated by class I MHC. Therefore, we investigated the influence of Ly49Q-class I MHC interactions on type I IFN secretion by pDCs in response to innate immune stimuli. As previously reported, overnight culture of splenic pDCs (129S1 strain) in the presence of CpG-oligonucleotide (ODN resulted in robust IFN-alpha production (6). However, when blocking mAb (21) specific for either Ly49Q or H-2Kb were added at the initiation of cell cultures, IFN-alpha secretion by pDCs was almost completely abrogated (Fig. 1 A). IL-12 secretion by pDCs could also be blocked using Ly49Q or H-2Kb mAb (Fig. 1 B). Thus, interaction of the ITIM-containing Ly49Q receptor with cognate H-2Kb ligand appears to be necessary for efficient TLR9-induced cytokine production by pDCs.
###end p 15
###begin p 16
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ly49Q&#8211;H-2K<sup>b</sup> interactions are necessary for pDC cytokine secretion after TLR9 stimulation.</bold>
###xml 673 674 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 681 682 672 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 698 700 689 691 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 706 708 697 699 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 718 719 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
Ly49Q-H-2Kb interactions are necessary for pDC cytokine secretion after TLR9 stimulation. (A and B) Splenic pDCs from 129S1 mice were isolated using mPDCA-1 microbeads and cultured overnight in the presence or absence of CpG-ODN and the indicated mAb. The supernatant was assayed by ELISA for IFN-alpha (A) or IL-12p70 (B). (C-E) Splenic pDCs from B6 (C and D) or 129S1 (E) mice were isolated with mPDCA-1 microbeads and cultured overnight in wells that had been precoated with the indicated mAb or recombinant MHC molecule in the presence or absence of 10 mug/ml CpG. The supernatant was assayed by ELISA for IFN-alpha. Isotype control antibodies for anti-Ly49Q, anti-H-2Kb, and Kb:Ig/OVA are rIgG2a, mIgG2a, and mIgG1, respectively. Anti-Ly49Q mAb 2E6 was used for these experiments. Data are presented as the mean of triplicate samples (error bars = SD). Results are representative of at least three independent experiments. ND, not detectable.
###end p 16
###begin p 17
###xml 280 281 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 570 578 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 657 658 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 894 902 874 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
To test the possibility that Ly49Q is directly involved in activating pDCs and stimulating IFN-alpha production upon receptor ligation, plate-bound mAb-mediated cross-linking experiments were used. Because pDCs from B6 mice are low producers of type I IFN compared with 129 mice (6), B6 pDCs were selected to enhance detection of increased IFN secretion. As previously reported, B6 pDCs cultured in the presence of CpG-ODN produced low levels of IFN-alpha. In contrast, when B6 pDCs were cultured on immobilized Ly49Q mAb, IFN-alpha production was increased 10-15-fold (Fig. 1 C). IFN-alpha secretion was also induced using immobilized recombinant ligand (Kb:Ig/OVA) showing that MHC directly activates pDCs. When this experiment was repeated with 129S1-derived pDCs, anti-Ly49Q cross-linking also significantly increased IFN-alpha production in response to CpG-ODN, albeit to a lesser extent (Fig. 1 E). Collectively, these results suggest that pDCs are synergistically activated by class I MHC and TLR9 ligands.
###end p 17
###begin p 18
###xml 355 357 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 359 361 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 724 739 716 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, D and E</xref>
The activation of pDCs through Ly49Q, an ITIM-bearing receptor, contrasts with the established functions of similar receptors in lymphocytes. However, our findings are complementary to those of recent studies reporting that immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors inhibit pDC activation, specifically IFN-alpha production (12, 22). To determine the outcome of simultaneous ITIM- and ITAM-mediated signal transduction in pDCs, purified cells were cultured in the presence of CpG-ODN on immobilized anti-Ly49Q, anti-Siglec-H (a DAP12-coupled receptor), or both. Using both B6- and 129-derived pDCs, inhibitory Siglec-H cross-linking blocked Ly49Q activation and suppressed IFN-alpha secretion (Fig. 1, D and E). Notably, the reported inhibitory effect of anti-Siglec-H was only seen with 129-derived pDCs, likely because of the larger basal IFN-alpha response seen using 129 versus B6 strain pDCs. Thus, ITAM-mediated inhibitory signals appear to be dominant and suppress ITIM-mediated stimulatory signals in pDCs.
###end p 18
###begin title 19
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
Targeted disruption of the Ly49q1 gene
###end title 19
###begin p 20
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 316 324 316 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 364 365 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox</sup>
###xml 359 368 359 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox</sup></italic>
###xml 534 545 534 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, B&#8211;D</xref>
###xml 567 568 567 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 562 568 562 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 613 614 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 608 614 608 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>2</sub></italic>
###xml 620 621 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 619 621 619 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q<sub>3</sub></italic>
###xml 714 722 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 779 780 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 780 783 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 774 783 774 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo</sup></italic>
###xml 792 793 792 793 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 793 796 793 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox</sup>
###xml 787 796 787 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox</sup></italic>
###xml 848 849 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 843 849 843 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 895 896 895 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 890 896 890 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>2</sub></italic>
###xml 901 902 901 902 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 900 902 900 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q<sub>3</sub></italic>
###xml 917 932 917 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, C and D</xref>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
To confirm the role of Ly49Q in pDC function, we sought to determine the effect of Ly49Q deficiency by targeted gene disruption in vivo. The Ly49q1 gene was disrupted in 129-background embryonic stem (ES) cells by inserting a floxed neomycin cassette into the StuI site of exon 2 adjacent to the ITIM coding region (Fig. 2 A). Founder mice shown to carry the Ly49q1lox allele and to exhibit germline competence were bred to 129S1 females. The resulting heterozygous offspring were interbred and genotyped by PCR or Southern blotting (Fig. 2, B-D). Note that the Ly49q1 probe also detects the closely related Ly49q2 and q3 pseuodogenes of the 129 gene cluster, as all three genes display the same WT KpnI fragment (Fig. 2 B). However, mice heterozygous or homozygous for the Ly49q1neo or Ly49q1lox alleles are easily distinguished by PCR using Ly49q1-specific primers that do not detect the Ly49q2 or q3 pseuodogenes (Fig. 2, C and D).
###end p 20
###begin p 21
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation of Ly49Q-null mice.</bold>
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PGK-Neo<sup>r</sup></italic>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo<sup>r</sup></italic>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 402 410 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PGK-Neo<sup>r</sup></italic>
###xml 443 444 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 444 447 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 438 447 438 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo</sup></italic>
###xml 457 458 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 458 461 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox</sup>
###xml 452 461 452 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox</sup></italic>
###xml 655 656 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 656 662 656 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/wt</sup>
###xml 650 662 650 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo/wt</sup></italic>
###xml 820 821 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 824 825 824 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 823 825 823 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q<sub>2</sub></italic>
###xml 832 833 832 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 831 833 831 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q<sub>3</sub></italic>
###xml 924 925 924 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 919 925 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>2</sub></italic>
###xml 931 932 931 932 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 930 932 930 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q<sub>3</sub></italic>
###xml 945 946 945 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 940 946 940 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 1064 1065 1064 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1065 1067 1065 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">wt</sup>
###xml 1059 1067 1059 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>wt</sup></italic>
###xml 1077 1078 1077 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1078 1081 1078 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 1072 1081 1072 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo</sup></italic>
###xml 1126 1127 1126 1127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1127 1133 1127 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox/wt</sup>
###xml 1121 1133 1121 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox/wt</sup></italic>
###xml 1225 1226 1225 1226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1226 1228 1226 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">wt</sup>
###xml 1220 1228 1220 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>wt</sup></italic>
###xml 1238 1239 1238 1239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1239 1242 1239 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox</sup>
###xml 1233 1242 1233 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox</sup></italic>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 365 368 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1309 1313 <span type="species:ncbi:10090">mice</span>
Generation of Ly49Q-null mice. (A) Ly49q1 gene disruption strategy. A 10-kb segment encompassing exons 1-4 was cloned by recombineering from BAC DNA, and a floxed PGK-Neor (neor) cassette was inserted into exon 2. After electroporation and selection, an ES clone possessing the predicted KpnI (K) fragment, as verified by Southern blotting, was electroporated with CMV-Cre plasmid, and the deletion of PGK-Neor was confirmed by PCR. Both Ly49q1neo and Ly49q1lox mice were created. PCR primers are shown by arrowheads. Boxes denote exons, and the location of the Southern probe is underlined. (B) Southern blot analysis. Genomic tail DNA of pups from Ly49q1neo/wt parent mice was digested with KpnI and analyzed by Southern blotting with the probe depicted in A. Note that the probe detects identical fragments from Ly49q1, q2, and q3 genes. (C) PCR analysis of tail DNA from mice in B. To eliminate confusion caused by Ly49q2 and q3 genes, Ly49q1-specific primers were designed. These primers were used to analyze tail DNA by PCR and to differentiate between Ly49q1wt and Ly49q1neo alleles. (D) PCR analysis of pups from Ly49q1lox/wt parent mice. Tail DNA was PCR amplified with primers flanking exon 2 to differentiate Ly49q1wt and Ly49q1lox alleles. (E) Lack of Ly49Q protein on DCs derived from Ly49Q-null mice. Ly49Q-null and -WT splenocytes were stained with a combination of mAb to CD11c/B220 (top) or Siglec-H/BST2 (bottom), and Ly49Q-specific mAb NS-34 or an isotype control. Ly49Q mAb staining intensity relative to isotype control mAb on gated cells is shown.
###end p 21
###begin p 22
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PGK-neo</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PGK-neo</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 309 316 309 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 303 316 303 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo/neo</sup></italic>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 327 334 327 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox/lox</sup>
###xml 321 334 321 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox/lox</sup></italic>
###xml 385 393 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 521 522 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 522 529 522 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox/lox</sup>
###xml 516 529 516 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox/lox</sup></italic>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 766 772 766 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
The insertion of a PGK-neo cassette or loxP site into exon 2 did not eliminate transcription, as revealed by RT-PCR (unpublished data). Analysis of the targeted cDNA revealed that insertion of PGK-neo or loxP interrupted the open reading frame, leading to premature termination. Both pDCs and mDCs from Ly49q1neo/neo and Ly49q1lox/lox mice lack any detectable Ly49Q by flow cytometry (Fig. 2 E and not depicted). We have reported that, in addition to pDCs, neutrophils also express low levels of Ly49Q protein (10). Ly49q1lox/lox blood neutrophils lacked all detectable reactivity with anti-Ly49Q mAb (unpublished data), confirming that Ly49Q is normally expressed at low levels on this cell type. Collectively, these data demonstrate that the open reading frame of Ly49q1 was disrupted successfully.
###end p 22
###begin p 23
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PGK-neo</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49g</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49r</italic>
###xml 233 240 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49e/s</italic>
###xml 250 259 250 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkg2a/c/e</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkg2d</italic>
###xml 279 280 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 384 389 384 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">wt/wt</sup>
###xml 379 389 379 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>wt/wt</sup></italic>
###xml 396 403 396 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 391 403 391 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>neo/neo</sup></italic>
###xml 414 421 414 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox/lox</sup>
###xml 409 421 409 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>lox/lox</sup></italic>
###xml 613 614 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 623 624 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 709 710 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>2</sub></italic>
###xml 716 717 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 715 717 715 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q<sub>3</sub></italic>
###xml 747 748 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 742 748 742 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q</italic>
###xml 855 860 855 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">wt/wt</sup>
###xml 850 860 850 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>wt/wt</sup></italic>
###xml 874 881 874 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox/lox</sup>
###xml 869 881 869 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>lox/lox</sup></italic>
The effect of introducing PGK-neo or a loxP site in Ly49q1 on neighboring gene expression was assessed by flow cytometry on both resting and IL-2-cultured NK cells with mAb recognizing proteins encoded by genes 5' (Ly49g, Ly49r, and Ly49e/s) and 3' (Nkg2a/c/e and Nkg2d) of Ly49q1. Both the distribution and lmean fluorescence intensity (MFI) of these receptors were the same on Ly49qwt/wt, Ly49qneo/neo, and Ly49qlox/lox NK cells (unpublished data). This indicates that the targeted insertion had no secondary effect on other genes located within the natural killer gene complex. Furthermore, Ly49Q-null pDC H-2Kb and H-2Db surface levels were identical to those of Ly49Q-WT pDCs (unpublished data). As Ly49q2 and q3 are likely pseudogenes, Ly49q1 will be referred to as Ly49q hereafter. Unless otherwise stated, all experiments were performed with Ly49qwt/wt (WT) or Ly49qlox/lox (Ly49Q-null) littermates in the high IFN-producing 129 background.
###end p 23
###begin title 24
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Hematopoiesis and pDC development in Ly49Q-null mice
###end title 24
###begin p 25
###xml 103 111 103 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 725 733 725 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 831 839 831 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
Fresh splenic pDCs are round cells with eccentric kidney-shaped nuclei, as visualized by Giemsa stain (Fig. 3 A). After activation with CpG-ODN, pDCs were larger and displayed a higher cytoplasmic to nucleus content, and the cytoplasm also appeared more vacuolated. The size and morphology of resting or activated pDCs from Ly49Q-WT and -null mice were similar. To determine whether the localization of Ly49Q-null pDCs is normal, three-color immunofluorescent staining using mPDCA-1, CD3, and CD19 mAbs was performed on splenic sections from untreated and CpG-ODN-treated animals. In the spleens of untreated animals, pDCs were mainly localized within the T cell zones and in lower numbers within marginal zone and red pulp (Fig. 3 B). In CpG-ODN-treated animals, the number of pDCs was increased and they tended to form clusters (Fig. 3 B). The majority of CpG-activated pDCs were found within the marginal zone and red pulp, as previously reported (23). Thus, no significant differences were observed in the localization of pDCs in WT and Ly49Q-null mice before or after CpG-ODN treatment.
###end p 25
###begin p 26
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Age-dependent increase in pDC proportion in Ly49Q-null mice.</bold>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 718 719 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 727 728 723 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 762 765 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 757 765 753 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>+/+</sup></italic>
###xml 789 796 785 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox/lox</sup>
###xml 784 796 780 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>lox/lox</sup></italic>
###xml 825 826 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 842 843 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
Age-dependent increase in pDC proportion in Ly49Q-null mice. (A) pDC size and morphology. pDCs were sorted as CD11c+B220+CD11b-DX5-CD3-CD19- cells from the spleen and cytocentrifuged on microspcope slides directly as resting pDCs or after incubation with 3 mug/ml CpG for 16 h. Slides were then stained with Giemsa solution. Bar, 5 mum. (B) Localization of splenic pDCs. Sections of spleen isolated from untreated young mice or mice injected i.v. with 10 mug/ml CpG 24 h earlier were stained with fluorescently labeled mAb to CD19 (B cells; green), CD3 (T cells; blue), and BST2 (pDCs; red). Bar, 50 mum. (C) Frequency of pDCs in primary and secondary lymphoid organs. Shown are the proportion of pDCs defined as CD11c+Siglec-H+ cells in lymphoid organs of Ly49q+/+ (closed bars) and Ly49qlox/lox (open bars) mice (6 wk old, n = 3; 9 mo old, n = 6). A similar pattern was observed with BST2 staining (not depicted). Data are presented as the mean of individual mice (error bars = SD). Results are representative of at least three independent experiments, except for C (9-mo-old mice), which was done twice.
###end p 26
###begin p 27
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 367 375 367 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 533 541 533 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 719 720 719 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 724 725 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1066 1067 1066 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1077 1078 1077 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1126 1130 <span type="species:ncbi:10090">mice</span>
###xml 1270 1274 <span type="species:ncbi:10090">mice</span>
The potential effect of Ly49Q absence on pDC frequency and distribution of cells in primary and secondary lymphoid organs was investigated in the Ly49Q-null mice. The pDC population as defined by CD11c+Siglec-H+ showed no significant difference in the proportion and total number of pDCs in the spleen, mesenteric lymph nodes, or bone marrow of young mice (6 wk old; Fig. 3 C and not depicted). However, in older mice (>9 mo old) there was approximately a twofold increase in the proportion and total number of pDCs in these organs (Fig. 3 C and not depicted). Myeloid lineage cells in various organs have been reported to express Ly49Q. There were no significant differences in the percentage and total number of CD11b+Gr-1+ cells in the bone marrow, spleen, or lymph nodes in either young or old mice (unpublished data). Similarly, blood neutrophil numbers and proportion in WT mice and Ly49Q-null littermates were not significantly different (unpublished data). In fact, no significant difference for any lineage tested was observed, including the B, NK, NKT, CD4+ T, or CD8+ T cells, or mDC subsets in either young or old mice (unpublished data). Therefore, Ly49Q deficiency appears to selectively affect pDC development and homeostasis, albeit only modestly. Young mice (5-8 wk old) were chosen for all functional experiments.
###end p 27
###begin title 28
Severe defect in TLR9-induced IFN-alpha production by Ly49Q-null pDCs
###end title 28
###begin p 29
###xml 525 533 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 618 619 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 672 680 660 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 810 818 798 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 996 997 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1012 1020 996 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1111 1126 1091 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, C and D</xref>
To determine the effect of Ly49Q deficiency on pDC activation and subsequent cytokine production, the response of Ly49Q-null pDCs to TLR9 agonists was evaluated. Splenic pDCs were isolated from WT and Ly49Q-null littermates using mPDCA-1-conjugated magnetic beads, cultured overnight in various concentrations of CpG-ODN, and the supernatant was assayed for IFN-alpha. Remarkably, Ly49Q-null pDC supernatants yielded approximately fivefold lower levels of IFN-alpha relative to supernatants from identically treated WT pDCs (Fig. 4 A). This finding is consistent with the earlier observation that Ly49Q binding to H-2Kb is necessary for TLR9-mediated IFN-alpha secretion (Fig. 1 A). In parallel, Ly49Q-deficient pDCs showed a significant defect in IL-12 secretion in response to CpG-ODN compared with WT pDCs (Fig. 4 B). The IL-12 defect was not as pronounced as that observed for IFN-alpha but is consistent with the decrease in IL-12 production observed upon mAb-mediated blockade of Ly49Q-H-2Kb interactions (Fig. 1 B). In contrast, TNF-alpha and IL-6 production were not compomised in Ly49Q-deficient pDCs (Fig. 4, C and D). Thus, Ly49Q-deficient pDCs possess an intrinsic defect in IFN-alpha production after stimulation with TLR9 agonists in vitro.
###end p 29
###begin p 30
###xml 0 78 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ly49Q-null pDCs display an IFN-&#945; production defect in response to CpG-ODN.</bold>
###xml 1069 1070 1041 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1071 1072 1043 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 659 664 <span type="species:ncbi:10090">mouse</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
Ly49Q-null pDCs display an IFN-alpha production defect in response to CpG-ODN. (A-D) IFN-alpha production by isolated pDCs after CpG-ODN stimulation. pDCs were isolated with mPDCA-1 microbeads from Ly49Q-null and -WT mice and cultured overnight in the presence of the indicated concentrations of CpG-ODN. Culture supernatants were assayed by ELISA for IFN-alpha (A), IL-12p70 (B), TNF-alpha (C), or IL-6 (D). (E) Induction of serum cytokines by CpG-ODN injection. Ly49Q-null and -WT littermates were injected with CpG-ODN + DOTAP, and blood samples were taken after 6 h for IFN-alpha ELISA. Uninjected mice served as controls. Each symbol represents a single mouse. (F) Serum IFN-alpha time course after CpG-ODN stimulation. Ly49Q-null and -WT littermates were injected with CpG-ODN + DOTAP, and blood was collected periodically over 36 h. Serum IFN-alpha levels were deduced by ELISA from three mice of each genotype for each time point. Data are representative of experiments done at least three times independently (error bars = SD). (G) pDCs were isolated from H-2KbDb-null or -WT (B6) mice and treated as in A. Horizontal bars represent means.
###end p 30
###begin p 31
###xml 134 136 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 451 459 439 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 724 726 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 977 985 953 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 1310 1311 1278 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1312 1313 1280 1281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1385 1386 1349 1350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1387 1388 1351 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1479 1487 1427 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 G</xref>
###xml 1839 1840 1783 1784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1319 1323 <span type="species:ncbi:10090">mice</span>
###xml 1759 1764 <span type="species:ncbi:10090">mouse</span>
Injection of mice with CpG-ODN leads to a rapid elevation of serum IFN-alpha peaking at 6 h after treatment that is mediated by pDCs (23). To determine whether the in vitro cytokine defect of Ly49Q-null pDCs had in vivo consequences, mice were injected with CpG-ODN, and serum IFN-alpha levels were evaluated after 6 h. Importantly, IFN-alpha serum levels in CpG-injected Ly49Q-null mice were consistently 5-10-fold less than those of WT littermates (Fig. 4 E). On the other hand, the sera of both cohorts showed similar levels of IL-12 (unpublished data). The normal serum IL-12 levels detected in Ly49Q-null mice after CpG injection were most likely caused by TLR9-mediated IL-12 production by cell types other than pDCs (24). A time-course experiment monitoring serum IFN-alpha levels confirmed that although maximal IFN-alpha levels occur 4-6 h after injection in WT mice, Ly49Q-null mice failed to attain a similar magnitude of IFN-alpha levels at any time point assayed (Fig. 4 F). Thus, Ly49Q-null mice display an inherent defect in IFN-alpha production in vivo, and IFN-alpha and IL-12 responses to CpG-ODN can be uncoupled in these mice. Although the absence of the receptor leads to clear defects in cytokine production, the effect of loss of the ligand is unknown. Thus, pDCs were isolated from H-2KbDb-null mice and were stimulated for IFN-alpha production by CpG-ODN. H-2KbDb-null pDCs showed approximately50% reduction in IFN-alpha secretion compared with WT pDCs (Fig. 4 G). These results are consistent with the hypothesis that Ly49Q-MHC interactions are necessary for cytokine production in pDCs, whereas the inhibition of IFN-alpha secretion was not as pronounced as for Ly49Q-null pDCs. Possible reasons for this difference may include the mouse strain background or that Ly49Q may have other ligands in addition to H-2Kb.
###end p 31
###begin p 32
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 464 472 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 620 628 620 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 763 764 763 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 765 766 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 845 853 845 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 945 946 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 985 986 985 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 796 801 <span type="species:ncbi:10090">mouse</span>
To address the question of whether Ly49Q/MHC interact in cis or trans to regulate pDC function, Ly49Q-null mice were crossed to H-2KbDb-null mice, and the resulting F1 mice were intercrossed to generate the four possible null phenotypes. pDCs from WT mice stain positively with soluble H-2Kb/OVA tetramer, and this binding is caused by Ly49Q, as shown by the complete absence of binding in Ly49Q-null mice and by previous blocking experiments with anti-Ly49Q mAb (Fig. 5 A, compare the top two dotplots) (21). In the absence of H-2Kb expression, binding of the H-2Kb tetramer is much stronger but still Ly49Q dependent (Fig. 5 A, compare the bottom two dotplots). Differential tetramer binding was not caused by differences in Ly49Q expression between WT and H-2KbDb-null mice, as pDCs from both mouse strains expressed similar levels of Ly49Q (Fig. 5 B). These results suggest that in WT pDCs, cis interactions between Ly49Q and endogenous H-2Kb are inhibiting binding of soluble H-2Kb tetramer to Ly49Q.
###end p 32
###begin p 33
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ly49Q binds to H-2K<sup>b</sup> in cis.</bold>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 540 541 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Ly49Q binds to H-2Kb in cis. (A) pDCs were isolated from the spleens of mice with the indicated genotypes with mPDCA-1 microbeads. Isolated pDCs were stained with PE-H-2Kb/OVA tetramer and allophycocyanin-anti-BST2 mAb and were analyzed by flow cytometry. Cells are gated on pDCs. The percentage of cells positively staining with PE-H-2Kb/OVA is shown. (B) Ly49Q levels on MHC-deficient pDCs. Splenocytes from the indicated strains (WT is B6) were stained for BST2, Siglec-H, and Ly49Q (NS34). The level of Ly49Q expression on BST2+Siglec-H+ cells is shown (shaded histogram). The open histogram represents the secondary reagent alone.
###end p 33
###begin title 34
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Normal TLR9 expression and pDC activation in Ly49Q-deficient mice
###end title 34
###begin p 35
###xml 538 546 538 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 835 843 831 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 859 867 855 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 1180 1195 1176 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B and C</xref>
Although the in vitro mAb-mediated blocking experiments are consistent with the phenotype of Ly49Q-null pDCs in vitro and in vivo, the defect in TLR9-induced cytokine production might be the result of factors other than the absence of Ly49Q. First, Ly49Q deficiency may have caused down-regulation of TLR9. To exclude this possibility, TLR9 expression was determined by RT-PCR and intracellular flow cytometry given the localization of TLR9 in endosomes. TLR9 levels were measured and found to be similar in both Ly49Q-WT and -null pDCs (Fig. 6 A and not depicted), suggesting that Ly49Q-null pDCs have an equal potential to bind CpG-ODN. Second, the almost complete lack of IFN-alpha secretion by Ly49Q-null pDCs may be caused by an inability of the cells to become fully activated. Downstream activation events in pDCs both in vivo (Fig. 6 B) and in vitro (Fig. 6 C) after CpG-ODN challenge were assessed by flow cytometry analysis of CD86 and class II MHC surface expression, and were found to be normal. The percentage of pDCs expressing CD86 and the level of CD86 on pDCs were similar between WT and Ly49Q-null pDCs after CpG treatment, even over an extended range of doses (Fig. 6, B and C). Similar observations were made for class II MHC (unpublished data). Collectively, these data suggest that the signaling pathways downstream of TLR9 that induce expression of CD86/class II MHC are different from those that lead to IFN-alpha production such that Ly49Q signaling modulates only the latter responses in pDCs.
###end p 35
###begin p 36
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Normal TLR9 and CD86 expression by Ly49Q-null pDCs.</bold>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 613 614 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 885 886 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 890 891 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
Normal TLR9 and CD86 expression by Ly49Q-null pDCs. (A) Splenocytes from Ly49Q-null and -WT mice were stained for Siglec-H and BST2, and were then permeabilized and stained for intracellular TLR9 or with an isotype control mAb. TLR9 (shaded histogram) or control (open histogram) expression on Siglec-H+BST2+ cells is shown. (B) In vivo activation of pDCs by CpG-ODN. Ly49Q-null and -WT littermates were injected with CpG-ODN + DOTAP. Uninjected mice served as controls. After 6 h, the splenocytes were isolated and stained for Siglec-H, BST2, and CD86, and were analyzed by flow cytometry. The percentage of CD86+ pDCs after 6 h is shown (error bars = SD). (C) In vitro activation of pDCs by CpG-ODN. pDCs from Ly49Q-null and -WT mice were isolated with mPDCA-1 microbeads and cultured overnight in the presence of the indicated concentrations of CpG-ODN. The following day, the CD11c+B220+ cells were analyzed by flow cytometry for CD86 surface expression. MFI (left) and the percentage of positive cells (right) are shown as the means of triplicate cultures +/- SD. Data are representative of at least three independent experiments.
###end p 36
###begin title 37
###xml 60 64 <span type="species:ncbi:10090">mice</span>
TLR7-mediated cytokine secretion is defective in Ly49Q-null mice
###end title 37
###begin p 38
###xml 456 457 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 573 588 565 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, A and B</xref>
###xml 809 817 801 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 277 303 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
To further characterize the extent of the defect in Ly49Q-null pDC cytokine responses, a distinct TLR pathway was evaluated. In addition to high levels of TLR9, pDCs also express TLR7, which can recognize single-stranded RNA motifs represented by such viruses as influenza and vesicular stomatitis virus. Similar to CpG-ODN stimulation, infection of isolated pDCs with influenza virus resulted in high levels of secreted IFN-alpha, as previously reported (6). Ly49Q-null pDCs produced fivefold less IFN-alpha and threefold less IL-12 than WT pDCs in response to influenza (Fig. 7, A and B). Active and inactivated influenza virus treatments gave similar results (unpublished data). In contrast, CD86 and class II MHC up-regulation of isolated pDCs in response to a TLR7 agonist was normal in Ly49Q-null pDCs (Fig. 7 C and not depicted). Therefore, TLR7-induced cytokine secretion is also attenuated in Ly49Q-null pDCs.
###end p 38
###begin p 39
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR7-induced cytokine production is defective in Ly49Q-null pDCs.</bold>
###xml 657 658 653 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 662 663 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 403 408 <span type="species:ncbi:10090">mouse</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
TLR7-induced cytokine production is defective in Ly49Q-null pDCs. (A and B) In vitro activation of pDCs by influenza virus. pDCs from Ly49Q-null and -WT mice were isolated using mPDCA-1 microbeads and cultured overnight in the presence or absence of 20 hemagglutinin units of influenza virus. Culture supernatants were assayed by ELISA for IFN-alpha (A) or IL-12p70 (B). Each symbol represents a single mouse. Horizontal bars represent means. (C) In vitro activation of pDCs by imiquimod. pDCs from Ly49Q-null and -WT mice were isolated using mPDCA-1 microbeads and cultured overnight with the indicated concentrations of imiquimod. The following day, CD11c+B220+ cells were stained with FITC-anti-CD86 and analyzed by flow cytometry for CD86 surface expression. MFI (left) and the percentage of positive cells (right) are shown as the means of triplicate cultures +/- SD. Data are representative of at least three independent experiments.
###end p 39
###begin title 40
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 60 63 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 65 69 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
Ly49Q-deficient mice exhibit diminished protection to mouse CMV (MCMV) infection
###end title 40
###begin p 41
###xml 401 403 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 405 407 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 750 758 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 725 729 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 765 769 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
The defect in IFN-alpha production seen in Ly49Q-null mice after TLR9 stimulation may have deleterious consequences during immune responses against pathogens that are detected through TLR9. Previous studies have reported that TLR9 deficiency promotes increased susceptibility to MCMV infection, as manifested by higher viral loads and defective production of multiple cytokines, including type I IFN (24, 25). As such, the defect in TLR9-dependent IFN-alpha production observed in Ly49Q-null mice may also lead to diminished pDC responses and altered innate immunity to DNA viruses like MCMV. In keeping with this, purified Ly49Q-null pDCs produce approximately threefold less IFN-alpha than WT pDCs in response to overnight MCMV infection in vitro (Fig. 8 A). The MCMV/pDC co-culture experiment confirms, independently of CpG-ODN, that pDCs from Ly49Q-null mice display defective IFN-alpha production when triggered through TLR9.
###end p 41
###begin p 42
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Reduced anti-MCMV responses by Ly49Q-null mice.</bold>
###xml 926 927 914 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 13 17 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 62 66 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 220 224 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 342 346 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 534 539 <span type="species:ncbi:10090">mouse</span>
###xml 592 597 <span type="species:ncbi:10090">mouse</span>
###xml 777 781 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
Reduced anti-MCMV responses by Ly49Q-null mice. (A) Decreased MCMV-induced IFN-alpha secretion by pDCs in vitro. Splenic pDCs were isolated with mPDCA-1 microbeads and cultured overnight in the presence of 200 PFU/ml of MCMV. Supernatants were harvested the following day. Supernatants were assayed for IFN-alpha levels by ELISA. (B) Greater MCMV proliferation in Ly49Q-null mice. Ly49Q-null and -WT mice were challenged with 600 or 6,000 PFU MCMV. After 1.5 or 3 d, spleens were harvested and viral titer was determined using BALB/c mouse embryo fibroblasts. Each symbol represents a single mouse. Data are representative of at least three independent experiments. Horizontal bars represent means. (C and D) Littermates of the indicated genotypes were infected with 6,000 PFU MCMV i.p., and serum samples were taken at the indicated time points after infection. IFN-alpha (C) or IL-12p70 (D) levels were determined by ELISA (n = 4 per time point). The means of individual mice +/- SD are shown.
###end p 42
###begin p 43
###xml 88 96 88 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 314 322 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49h</italic>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 558 561 558 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox</sup>
###xml 553 561 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>lox</sup></italic>
###xml 907 915 907 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 999 1000 999 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1251 1259 1243 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
###xml 1301 1309 1293 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 D</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 772 776 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 873 877 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 1090 1094 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1163 1167 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1210 1214 <span type="species:ncbi:10090">mice</span>
###xml 1577 1581 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1668 1672 <span type="species:ncbi:10090">mice</span>
###xml 1676 1680 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
To confirm these findings in vivo, Ly49Q-null mice were infected with MCMV. As shown in Fig. 8 B, splenic viral titers were consistently higher in Ly49Q-null mice versus WT control animals. Although not all experiments showed a statistically significant difference between the two cohorts (e.g., day 3, 6,000 PFU; Fig. 8 B), the detection of impaired viral immunity may be complicated by the susceptible Ly49H- 129 background of these mice (26). Because the Ly49h gene conferring resistance to MCMV in B6 mice (27, 28) is <300 kb away from the targeted Ly49qlox allele, these experiments could not be repeated on the MCMV-resistant B6 background at this time. Notwithstanding this, the majority of experiments did reveal a statistically significant increase in Ly49Q-null MCMV titers when performed using either an early time point (1.5 d after infection) or a low initial MCMV inoculum (600 PFU), or both (Fig. 8 B). In agreement with our findings, TLR9-null mice on a susceptible background (Ly49H- BALB/c) display a similarly small but significant increase in splenic viral titers after MCMV infection (24). Serum IFN-alpha and IL-12 levels peak at 36 h after MCMV infection. At this time point, Ly49Q-null mice display normal levels of IFN-alpha (Fig. 8 C) and slightly decreased IL-12p70 levels (Fig. 8 D). This suggests that in addition to pDCs, other cell types can contribute to serum IFN-alpha/IL-12 levels by 36 h after infection. Collectively, these experiments demonstrate that Ly49Q-null pDCs exhibit a functional deficiency in IFN-alpha production in response to MCMV infection in vitro, and this translates into an enhanced susceptibility of Ly49Q-null mice to MCMV infection in vivo.
###end p 43
###begin title 44
DISCUSSION
###end title 44
###begin p 45
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49</italic>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 353 354 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 447 448 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 728 729 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 924 925 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Ly49q is a highly conserved Ly49 found in all mouse strains characterized to date (16). Ly49Q is also unique in being expressed on pDCs, in contrast to all other Ly49s. We have previously shown, using the BWZ lacZ-based reporter cell assay, that H-2Kb is a high affinity ligand for Ly49Q (21). In this study, we confirm the specificity of Ly49Q for H-2Kb in a functional assay (IFN-alpha secretion) using fresh ex-vivo pDCs. Remarkably, Ly49Q-H-2Kb interactions appear to be required for optimal TLR7- and TLR9-dependent stimulation of cytokine production by pDCs, as indicated by the drastic reduction in CpG-mediated IFN-alpha and IL-12 secretion upon mAb-mediated blockade of either Ly49Q receptor or its cognate ligand, H-2Kb. In further support of this hypothesis, purified pDCs cultured in the presence of low concentrations of CpG-ODN produced high levels of IFN-alpha when stimulated on immobilized Ly49Q mAb or H-2Kb/Ig fusion protein but not in the presence of CpG-ODN alone. Collectively, these findings demonstrate that Ly49Q-class I MHC interactions positively regulate TLR signals and subsequent cytokine production in pDCs.
###end p 45
###begin p 46
###xml 563 565 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 491 495 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
In confirmation of the in vitro mAb blocking experiments, Ly49Q-null mice show a severe defect in systemic IFN-alpha levels (75-100% reduction) upon challenge with CpG-ODN. This defect is likely caused by the hyporesponsiveness of Ly49Q-null pDCs, as purified pDCs from these mice exhibit similarly decreased IFN-alpha responses upon CpG-mediated stimulation in isolation. Ly49Q-null pDCs also show a defect in the production of IFN-alpha after overnight culture with MCMV. Both CpG-ODN and MCMV stimulate IFN-alpha production by pDCs in a TLR9-dependent manner (24). However, TLR9 mRNA and protein expression levels in Ly49Q-null pDCs are normal, as deduced by semiquantitative RT-PCR and intracellular staining, respectively. The Ly49Q-null defect similarly affects TLR7, as TLR7-dependent stimulation of isolated Ly49Q-null pDCs results in highly decreased levels of IFN-alpha relative to WT pDCs. Notably, in addition to IFN-alpha levels, Ly49Q-null pDCs also exhibit decreased IL-12p70 levels in response to CpG-ODN or influenza stimulation. Thus, Ly49Q-null pDCs possess an intrinsic cytokine production defect in response to TLR7 and TLR9 agonists. Interestingly, however, the activation status of Ly49Q-null pDCs seems normal over a wide range of CpG-ODN concentrations, at least with respect to up-regulation of CD86 and class II MHC surface expression, TNF-alpha and IL-6 production, morphological change, and migration within the spleen. This suggests that TLR9 stimulation results in multiple signaling pathways leading to pDC activation, but that Ly49Q regulates only the signal transduction pathway leading to IFN-alpha secretion.
###end p 46
###begin p 47
###xml 301 303 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 458 460 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 287 299 <span type="species:ncbi:11191">Sendai virus</span>
###xml 652 657 <span type="species:ncbi:10090">mouse</span>
The phenotype of pDCs from Ly49Q-null mice is similar to that observed for Ly49Q-negative pDCs from WT bone marrow. Omatsu et al. found that Ly49Q-negative pDCs produced significantly less IFN-alpha/beta than their Ly49Q-positive counterparts when cultured in the presence of CpG-ODN or Sendai virus (19). In contrast, Kamogawa-Schifter et al. observed comparable IFN-alpha production levels from the two pDC subsets in vitro after stimulation with CpG-ODN (11). It is not immediately clear why there is a discrepancy in IFN-alpha production among Ly49Q-positive versus -negative pDCs in these two studies, as similar isolation procedures and the same mouse strain (BALB/c) were used. The data presented in this paper agree with the former study, in that the ability of pDCs to produce large amounts of IFN-alpha appears to depend on Ly49Q expression and function.
###end p 47
###begin p 48
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1184 1186 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1624 1626 1612 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1628 1630 1616 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1778 1780 1766 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1904 1906 1892 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1240 1244 <span type="species:ncbi:10090">mice</span>
###xml 1728 1732 <span type="species:ncbi:10090">mice</span>
The positive regulation of TLR9 signaling by Ly49Q is at first counterintuitive, given that the ITIM-bearing Ly49Q receptor has the characteristics of an inhibitory Ly49 family member. Similar Ly49 receptors expressed by NK cells undergo tyrosine phosphorylation of their cytoplasmic ITIM in response to receptor engagement, resulting in the recruitment of SHP-1/2 (29). Ly49-associated SHP-1/2 are then thought to antagonize stimulatory signals initiated through ITAM-bearing adaptor molecules such as DAP12. For example, the ITIM-bearing Ly49G receptor has been demonstrated to suppress DAP12-dependent Ly49D-mediated cytotoxicity and cytokine production (30). Notably, the ability of the Ly49Q ITIM to associate with SHP-1/2 is intact, at least in reconstitution experiments using transfected cell lines (10). Thus, if Ly49Q is an inhibitory receptor, how does it function to relay TLR7/9-induced signals or amplify TLR7/9-mediated signal transduction? Interestingly, there are clues from experiments performed using DAP12-null mice that may offer a possible mechanism. Specifically, DAP12-null pDCs were reported to produce significantly more IFN-alpha after CpG-ODN stimulation (31), as opposed to the decreased response of Ly49Q-null mice. The resulting conclusion was that DAP12 may negatively regulate TLR7/9 signal transduction and, in turn, that DAP12-coupled receptors on pDCs may inhibit IFN-alpha secretion upon cross-linking. In support of this hypothesis, the pDC-expressed and DAP12-associated surface proteins Nkp44 and Siglec-H do indeed inhibit CpG-induced IFN-alpha secretion upon mAb-mediated ligation (12, 22). In this respect, macrophages and pDCs are functionally similar, as macrophages from DAP12-null mice produce more cytokines after TLR engagement (32). Furthermore, the DAP12-coupled TREM2 surface receptor appears to deliver constitutive inhibitory signals in macrophages (33).
###end p 48
###begin p 49
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
The apparent stimulatory role of Ly49Q in pDCs could be caused by antagonism of inhibitory DAP12 signal transduction by SHP-1/2 recruited as a result of Ly49Q-MHC interaction. In this model, DAP12 signaling would be constitutive like TREM2 function in macrophages (33). Although the convergence point between the DAP12 and TLR9 signaling pathways is unclear, another possibility is that downstream Ly49Q signaling molecules may directly regulate the TLR9 signaling cascade independently of DAP12 function. A third mechanism behind Ly49Q function may include an alternative signaling pathway found in pDCs, one which is distinct from canonical inhibitory Ly49 signaling in NK cells and does not involve the recruitment of tyrosine phosphatases. Evidence for this possibility includes Ly49Q-transfected macrophage cell lines, which show an increase in tyrosine-phosphorylated proteins in whole-cell lysates after mAb-mediated cross-linking of Ly49Q (10).
###end p 49
###begin p 50
###xml 407 409 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 411 413 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 822 824 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 873 874 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1149 1155 1137 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
The mechanistic link between Ly49Q function and IFN-alpha secretion is unknown. However, an interesting parallel may exist between NK cells and pDCs in this regard. Two reports have suggested that mature splenic NK cells lacking all self-specific MHC-binding inhibitory receptors (NKG2A and Ly49C/I in B6 mice) are hyporesponsive with respect to the killing of target cells and the production of IFN-gamma (34, 35). Thus, B6 strain NK cells expressing NKG2A and/or Ly49C/I have been referred to as being "licensed" or "armed." It is tempting to speculate that pDCs like NK cells may also require the expression of at least one self-specific MHC-binding inhibitory receptor to become fully functional IFN-alpha producers. This hypothesis is consistent with the hyporesponsiveness observed for immature Ly49Q-negative pDCs (19). Because Ly49Q binds with high affinity to H-2Kb, a self-specific determinant expressed in 129 strain Ly49Q-null mice, the lack of a self-MHC-specific inhibitory signal during pDC development in Ly49Q-null mice may render these cells anergic. However, the recapitulated phenotype using WT pDCs in mAb blocking experiments (Fig. 1) argues against Ly49Q-null pDCs being anergic.
###end p 50
###begin p 51
###xml 124 126 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 168 169 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 863 864 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 913 914 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1074 1075 1044 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1139 1141 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1284 1288 <span type="species:ncbi:10090">mice</span>
###xml 1300 1304 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1459 1463 <span type="species:ncbi:10090">mice</span>
###xml 1554 1558 <span type="species:ncbi:10090">mice</span>
Type I IFN is indispensable for resistance to a wide range of viruses, as shown by studies using IFN-alpha/betaR-null mice (36). Ly49Q-null mice, which are on the Ly49H- 129 background, also display a severe IFN production defect, as well as a consistent and statistically significant increase in susceptibility to MCMV. However, the susceptibility of Ly49Q-null mice to virus infection is not as profound as that observed in IFN-alpha/betaR-null mice. There are several possible reasons for this observation. First, although the magnitude of the IFN-alpha response to CpG-ODN challenge in WT mice far exceeds that of Ly49Q-null mice, the latter still yield up to 15-25% of WT serum IFN-alpha levels. This lower yet detectable IFN-alpha production may be sufficient to mount resistance to viral infection. This hypothesis is consistent with the phenotype of Ly49H+ B6 mice, which produce low levels of IFN-alpha (6) but are nonetheless sufficient for protection against MCMV and other viruses. In agreement with our study, TLR9-null mice on a BALB/c (MCMV susceptible; Ly49H-) background also only show a small increase in susceptibility (24), as would be expected if Ly49Q does indeed regulate TLR signaling. Furthermore, normal systemic IFN-alpha levels were observed in Ly49Q-null mice 36 h after MCMV infection despite their defective IFN-alpha responses to synthetic CpG-ODN. Therefore, although pDC cytokine production is compromised in Ly49Q-deficient mice and does confer limited susceptibility to viral infection, the residual capacity of these mice to produce antiviral cytokines probably affords sufficient protection. Whether these residual cytokines are made by Ly49Q-null pDCs or other cell types is not clear.
###end p 51
###begin p 52
###xml 849 850 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
Based on the data generated from mAb-mediated blocking assays and functional analyses of Ly49Q-null pDCs in vitro, as well as in vivo analyses of Ly49Q-null mice, we conclude that pDC function, in particular IFN-alpha secretion, is regulated by class I MHC. The ability of pDCs to recognize class I MHC molecules is imparted by the lectin-like Ly49Q receptor, which in turn potentiates the capacity of pDCs to produce cytokines in response to TLR7 and TLR9 agonists. Loss of this self-recognition mechanism results in severe defects in IFN-alpha and IL-12 production by pDCs. Thus, Ly49Q-MHC interactions positively regulate pDC cytokine production triggered through TLR. Therefore, the down-regulation of class I MHC by certain viruses like MCMV could also result in the attenuation of pDC antiviral defense mechanisms in addition to evasion of CD8+ T cell responses. Interestingly, despite bearing a consensus ITIM sequence, the function of Ly49Q on pDCs appears to be stimulatory in nature. Although this is somewhat paradoxical, it is nonetheless consistent with the reported counterregulatory function of DAP12-coupled receptors in pDCs, which appear to be inhibitory.
###end p 52
###begin title 53
MATERIALS AND METHODS
###end title 53
###begin title 54
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 54
###begin p 55
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1</sup>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1</sup>
###xml 62 78 62 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H-2Kb<sup>tm1</sup>H-2Db<sup>tm1</sup></italic>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">Mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
129S1 and B6 mice were purchased from the Jackson Laboratory. H-2Kbtm1H-2Dbtm1 (KbDb-KO) mice on a B6 background were purchased from Taconic. Mice were maintained and bred in the Clinical Research Institute of Montreal (IRCM) specific pathogen-free animal facilities. All manipulations performed on animals were in accordance with IRCM guidelines and were approved by the IRCM Animal Ethics Committee. Unless otherwise mentioned, all mice used for experiments were 5-8 wk of age.
###end p 55
###begin title 56
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Generation of Ly49Q-null mice.
###end title 56
###begin p 57
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 861 868 861 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 929 930 929 930 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 930 933 930 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 924 933 924 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo</sup></italic>
###xml 1092 1093 1092 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1093 1096 1093 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 1087 1096 1087 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo</sup></italic>
###xml 1106 1107 1106 1107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1107 1110 1107 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox</sup>
###xml 1101 1110 1101 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox</sup></italic>
###xml 1226 1227 1226 1227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1221 1227 1221 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub></italic>
###xml 1336 1340 1336 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49</italic>
###xml 1413 1415 1413 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 1599 1602 1599 1602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 1594 1602 1594 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sup>neo</sup></italic>
###xml 1828 1829 1828 1829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1829 1832 1829 1832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lox</sup>
###xml 1823 1832 1823 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>lox</sup></italic>
###xml 2055 2056 2055 2056 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2056 2059 2056 2059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 2050 2059 2050 2059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ly49q<sub>1</sub><sup>neo</sup></italic>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 967 970 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
###xml 1183 1187 <span type="species:ncbi:10090">mice</span>
###xml 1445 1449 <span type="species:ncbi:10090">mice</span>
We previously identified 129S6 bacterial artificial chromosome (BAC) clones containing Ly49q1 (15). A 10-kb segment centered on exon 2 was retrieved from BAC 34o6 into the pMCITKpANhe vector by lambda red-mediated recombineering in EL350 cells, as previously described (37). To complete the targeting construct, a floxed PGK-neomycin cassette from PL400 was inserted into a unique StuI site in exon 2. The complete targeting construct sequence was confirmed. R1 ES cells (129Sv x 129Sv-CP) were electroporated with NotI-linearized targeting vector DNA and were then selected in G418. Homologous recombination in ES cells was assessed by Southern blotting. A homologous recombination efficiency of 1% was observed (6 out of 600). The germline competency of these clones was confirmed by generating heterozygous founder mice, which were then bred to achieve Ly49Qneo/neo homozygosity. An ES clone carrying a properly targeted Ly49q1neo allele was electroporated with a CMV-Cre vector (a gift from D. Lohnes, University of Ottawa, Ottawa, Canada) and screened for neomycin deletion by PCR. Ly49q1neo and Ly49q1lox founder mice were generated by the IRCM MicroInjection Service. Founder mice that could transmit the targeted Ly49q1 allele to the germline were bred to 129S1 females to maintain a 129 background, which was confirmed for the Ly49 locus by 4E5 versus 12A8 staining of NK cells, as previously described (38). The resulting heterozygous mice were bred, and homozygous WT and Ly49Q-null littermates were used in all experiments unless otherwise indicated. Southern blot analysis for the Ly49qneo allele was performed using an intron 4 probe cloned into pCR2.1TOPO (Invitrogen), prepared by amplifying BAC 34o6 DNA with 5'-TATGACTTCTTGGAGAGAGT-3' (sense primer) and 5'-TTCACGTGGGCCTAGAATTT-3' (antisense primer). The Ly49q1lox allele was detected by PCR with 5'-CCTAAAAGTAATTGCTGTGACTATT-3' (sense primer) and 5'-CTTTCTAACTAGCTAACAACAG-3' (antisense primer). A substitute reverse primer, 5'-CCGAATATCATGGTGGAAAATGGC-3', was used to amplify the Ly49q1neo allele. The following PCR cycling parameters used were: 94degreesC for 30 s, 55.5degreesC for 30 s, and 72degreesC for 30 s, for 35 cycles.
###end p 57
###begin title 58
pDC isolation and in vitro activation.
###end title 58
###begin p 59
###xml 592 593 578 579 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 673 674 650 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 779 783 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
Mouse spleens were injected with collagenase (Roche), minced, and incubated for 20 min at 37degreesC. After incubation, splenocytes were crushed in cold PBS-BSA-EDTA and strained through a 70-muM filter. RBCs were removed by incubation with ACK lysis buffer for 5 min at 4degreesC. Isolated splenocytes were maintained throughout the procedure in cold PBS-BSA-EDTA. Anti-mPDCA-1-conjugated microbead (Miltenyi Biotec) labeling was performed according to the manufacturer's protocol. Isolated pDCs were seeded at 100,000 cells per well in 200 mul of pDC medium (RPMI 1640, 10% FBS, pen/strep, l-glutamine, 2-beta-mercaptoethanol) and cultured for 16 h at 37degreesC in 5% CO2 in a humidified atmosphere in the presence of CpG-ODN 10103 or 2336 (Coley Pharmaceuticals), imiquimod, MCMV, or influenza at the indicated concentrations/PFU/hemagglutinin units. Supernatants were collected and frozen.
###end p 59
###begin title 60
In vivo pDC activation.
###end title 60
###begin p 61
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 237 241 <span type="species:ncbi:10090">Mice</span>
Mice were injected through the tail vein with CpG-ODN plus 1,2-dioleoyloxy-3-trimethylammonium-propane (DOTAP; Roche) preparation (170 mul CpG-ODN diluted in sterile PBS plus 30 mul DOTAP) or imiquimod (R-837; InvivoGen) in 200 mul PBS. Mice were bled through the cheek vein at the indicated time points after injection. Serum was analyzed by ELISA.
###end p 61
###begin title 62
Virus infections.
###end title 62
###begin p 63
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 98 102 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
Influenza strain A HK X31 H3N2 was a gift from T. Watts (University of Toronto, Toronto, Canada). MCMV (Smith strain) preparation, injection, and plaque assay were performed as previously described (39).
###end p 63
###begin title 64
ELISAs.
###end title 64
###begin p 65
###xml 745 746 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 748 749 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 138 141 <span type="species:ncbi:10116">rat</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 351 356 <span type="species:ncbi:10090">mouse</span>
###xml 445 451 <span type="species:ncbi:9986">rabbit</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
###xml 579 585 <span type="species:ncbi:9793">donkey</span>
###xml 591 597 <span type="species:ncbi:9986">rabbit</span>
###xml 616 627 <span type="species:ncbi:3704">horseradish</span>
Mouse IFN-alpha was determined by sandwich ELISA. In brief, 96-well microtiter plates were coated overnight at 4degreesC with 5 mug/ml of rat anti-mouse IFN-alpha antibody (RMMA-1; PBL Biomedical Laboratories) diluted in 0.1 M of sodium carbonate buffer. Wells were blocked for 1 h with PBS/10% FBS and incubated for 2 h with samples or a recombinant mouse IFN-alpha standard (Sigma-Aldrich). IFN-alpha was detected with 100 ng/ml of polyclonal rabbit anti-mouse IFN-alpha antibody (PBL Biomedical Laboratories) for 24 h at room temperature, washed, and incubated for 1 h with a donkey anti-rabbit IgG conjugated to horseradish peroxidase (GE Healthcare), followed by 20 min in 3,3',5,5'-tetramethylbenzidine substrate (Sigma-Aldrich), and 1 M H2SO4 was added to stop the reaction. Between incubations, plates were washed three times with PBS/0.05% Tween-20. Optical density was read at 450 nm with a microtiter plate reader (MDS Analytical Technologies). IL-12p70, IL-6, and TNF-alpha production by pDCs was assayed using commercial ELISA kits (BD).
###end p 65
###begin title 66
Immunofluorescence and FACS analysis.
###end title 66
###begin p 67
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 331 332 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 508 509 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 873 876 <span type="species:ncbi:10116">rat</span>
###xml 975 979 <span type="species:ncbi:9925">goat</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
The following FACS mAbs were used: biotin-440c (anti-Siglec-H; Cell Sciences), allophycocyanin-mPDCA-1 (anti-BST2; Miltenyi Biotec), FITC-CD86, 2E6 (anti-Ly49Q; eBioscience), allophycocyanin-B220, PE-CD11c, and streptavidin-PE were purchased from BD. NS-34 (anti-Ly49Q) was prepared as previously described (10). PE-conjugated H-2Kb/OVA tetramer contains human beta2 microglobulin and was purchased from Beckman Coulter. For all FACS analyses, cells were first washed in FACS buffer (PBS, 0.5% BSA, 0.02% NaN3), and were then incubated for 20 min at 4degreesC with fluorochrome-conjugated antibodies. Two-step staining involved an additional incubation for 20 min with the appropriate secondary antibody at 4degreesC, followed by a wash in FACS buffer. Stained cells were analyzed with a flow cytometer (FACSCalibur; BD). Three-color immunofluorescent staining with biotin-rat anti-mPDCA-1 plus streptavidin-Alexa Fluor 594, hamster anti-CD3epsilon (BD) plus Alexa Fluor 647-goat anti-hamster IgG (Invitrogen), and FITC-anti-CD19 (BD) was performed on slide-mounted 10-mum spleen sections from untreated and CpG-ODN-injected mice. Slides were viewed on a confocal microscope (Axiovert 100M; Car Zeiss, Inc.).
###end p 67
###begin title 68
Giemsa staining.
###end title 68
###begin p 69
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 253 254 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Fresh or CpG-ODN-cultured pDCs were cytocentrifuged onto glass slides, fixed in methanol for 10 min, and air dried. Slides were stained with modified Giemsa stain solution (Sigma-Aldrich) diluted 1:10 in distilled H2O for 10 min, rinsed with distilled H2O, and mounted. Pictures were obtained with a microscope (Axiophot; Carl Zeiss, Inc.).
###end p 69
###begin title 70
Statistical analysis.
###end title 70
###begin p 71
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Unless otherwise indicated, all P values were calculated with the two-tailed Student's t test.
###end p 71
###begin p 72
We thank Dr. P. Liu for assistance with BAC recombineering; Dr. Q. Zhu for ES cell selection and blastocyst injections; Drs. S.K. Anderson and A. Veillette for helpful discussion; Drs. J. Carlyle, W.-K. Suh, J. Di Noia, and J.-F. Cote for critical reading of the manuscript; and E. Massicotte and M. Dupuis for cell sorting.
###end p 72
###begin p 73
This work was supported by an operating grant (MOP 62841) from the Canadian Institutes of Health Research (CIHR). L-H. Tai is supported by a CIHR Cancer Training Program scholarship. S. Belanger is supported by a Fonds de la recherche en sante Quebec scholarship. A.P. Makrigiannis is supported by a New Investigator Award from the CIHR.
###end p 73
###begin p 74
The authors have no conflicting financial interests.
###end p 74

